COLE SZAKAL: Open Payments
NPI 1376375378 · DURAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 20 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $515
Food & beverage: $416Education: $99
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $125 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 12 | $106 |
| Actelion Pharmaceuticals US, Inc. | 1 | $99 |
| Alnylam Pharmaceuticals Inc. | 2 | $84 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| PFIZER INC. | 1 | $33 |
| HEARTFLOW, INC. | 1 | $20 |
Products named: REPATHA, LifeVest, OPSUMIT, AMVUTTRA, LEQVIO, VYNDAQEL, FFRct, ONPATTRO.
Industry payments across MI — which companies pay providers there.
